Aim:

To study the effect of yohimbine in the treatment of men with orgasmic dysfunction.

Methods:

A 20-mg dose of yohimbine was first given to 29 men with orgasmic dysfunction of different aetiology in the clinic. Patients were then allowed to increase the dose at home (titration) under more favourable circumstances. The outcome and side effects were subsequently assessed.

Results:

The patients were classified into three groups of orgasmic dysfunction: primary complete (13), primary incomplete (8) and secondary (8). Nocturnal emissions were present in 75%, 40% and 50% of patients in the above groups, respectively (overall average 62%). The men presented because of fertility problems (52%) or because they wanted to experience the pleasure of orgasm (48%). Of the 29 patients who completed the treatment, 16 managed to reach orgasm and were able to ejaculate either during masturbation or sexual intercourse. A further three achieved orgasm, but only with the additional stimulation of a vibrator. A history of preceding nocturnal emissions was present in 69% of the men in whom orgasm was induced but only 50% who failed treatment. Of the patients, two have subsequently fathered children (one set of twins) and another 3 men were also cured. Side effects were not sufficient to cause the men to cease treatment.

Conclusion:

Yohimbine is a useful treatment option in orgasmic dysfunction.

References

1. Hendry WF, Althof SE, Benson GS, Haensel SM, Hull EM, Kihara K, et al. Erectile dysfunction-WHO, SIU & ISSIR 1st International Consultation on Erectile dysfunction. Committee 13. Male orgasmic and ejaculatory disorders. Plymbridge Distributors, 2000: 479–99.
2. Brindley GS, Gillan P. Men and women who do not have orgasms. Br J Psychiatry 1982; 140: 351–6. | Article | PubMed | ChemPort |
3. Buch J. Disorders of ejaculation. In Bennett A, editor. Impotence. Philadelphia: Saunders; 1994. p 186–9.
4. McMahon CG, Samali R. Pharmacological treatment of premature ejaculation. Curr Opin Urol 1999; 9: 553–61. | Article | PubMed | ChemPort |
5. Vickers MA. The forgotten dysfunction: a pharmacological approach to premature ejaculation. In Morales A, editor. Erectile dysfunction-issues in current pharmacotherapy. Alvaro Morales London Martin Dunitz. 1998; 253–67.
6. Hendry WF. Disorders of ejaculation: congenital, acquired and functional. BJU Int 1998; 82: 331–41. | Article | ChemPort |
7. Waldinger MD, Hengeveld MW, Zwinderman AH. Ejaculation retarding properties of paroxetine in patients with primary premature ejaculation: a double blind, randomised, dose response study. Br J Urol 1997; 79: 592–5. | Article | PubMed | ISI | ChemPort |
8. Ohl DA. Electroejaculation. Urol Clin N Am 1993; 20: 181–8. | ChemPort |
9. Brindley GS, Sauerwein D, Hendry WF. Hypogastric plexus stimulators for obtaining semen from paraplegic men. Br J Urol 1989; 64: 72–7. | Article | PubMed | ISI | ChemPort |
10. Brindley GS, Scott GI, Hendry WF. Vas cannulation with implanted sperm reservoirs for obstructive azoospermia or ejaculatory failure. Br J Urol 1996; 58: 721–3. | Article |
11. Beckerman H, Becher J, Lankhorst GJ. The effectiveness of vibratory stimulation in anejaculatory men with spinal cord injury. Paraplegia 1993; 31: 689–99. | PubMed | ISI | ChemPort |
12. Weiss RJ. Effects of anti-hypertensive agents on sexual function. Am Fam Physician 1991; 44: 2075–82. | PubMed | ISI | ChemPort |
13. Brindley GS. Reflex ejaculation under vibratory stimulation in paraplegic men. Paraplegia 1981; 19: 2299–302.
14. Ernst E, Pittler MH. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol 1998; 159: 433–6. | Article | PubMed | ChemPort |
15. Vogt HJ, Brandl P, Kockott G, Schmitz JR, Wiegand MH, Shadrack J, et al. Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction. Int J Imp Res 1997; 9: 155–61. | Article | ChemPort |
16. Peters RH, Koch PC, Blythe BL. Differential effects of yohimbine and naloxone on copulatory behaviors of male rats. Behav Neurosci 1988; 102: 559–64. | Article | PubMed | ChemPort |
17. Brindley GS. Impotence and Ejaculatory failure. Rushton DN, editor. Handbook of Neurourology. New York: Marcel Dekker; 1994: 335–6, 344–6.
18. Goldberg MR, Robertson D. Yohimbine, a pharmacological probe for the study of the ₂-adrenoceptor. Pharmacol Rev 1983; 35: 143. | PubMed | ChemPort |
19. Mann K, Klinger T, Noe S, Roschke J, Muller S, Benkeir O. Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction. Arc Sex Behav 1996; 25: 1. | Article | ChemPort |
20. Riley AJ, Goodman R, Kellet JM, Orr R. Double-blind trial of yohimbine hydrochloride in the treatment of erection inadequacy. Sex Marital Ther 1989; 4: 17.
21. Susset JG, Tessier CD, Wincze J, Bansal S, Malhotra C, Schwacha MG. Effect of yohimbine hydrochloride on erectile impotence. Urology 1989; 141: 1360. | ChemPort |